MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer

BACKGROUND: Challenges in medical care posed by rapid tumor progression, individualized responses to therapy, and the heterogeneous characteristics of breast cancer (BRCA) highlight the urgent need for new treatment strategies, as well as therapeutic and prognostic markers. Accumulating evidence has...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Meng, Xiao, Ran, Wang, Xinru, Xiong, Youyi, Duan, Zhenfeng, Li, Duolu, Kan, Quancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908185/
https://www.ncbi.nlm.nih.gov/pubmed/35280383
http://dx.doi.org/10.21037/atm-22-97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908185/
https://www.ncbi.nlm.nih.gov/pubmed/35280383
http://dx.doi.org/10.21037/atm-22-97

Ejemplares similares